Bionano Genomics Inc [NASDAQ: BNGO] stock went on a downward path that fall over -6.88% on Tuesday, amounting to a one-week price decrease of less than -19.20%.
Over the last 12 months, BNGO stock dropped by -85.24%. The one-year Bionano Genomics Inc stock forecast points to a potential upside of 82.0. The average equity rating for BNGO stock is currently 3.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $25.18 million, with 139.82 million shares outstanding and 139.11 million shares in the current float. Compared to the average trading volume of 7.52M shares, BNGO stock reached a trading volume of 8363213 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Bionano Genomics Inc [BNGO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Bionano Genomics Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 15, 2024. The new note on the price target was released on September 10, 2024, representing the official price target for Bionano Genomics Inc stock. Previously, the target price had yet another raise to $4, while Scotiabank analysts kept a Sector Outperform rating on BNGO stock.
The Average True Range (ATR) for Bionano Genomics Inc is set at 0.04, with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 0.76. The Price to Book ratio for the last quarter was 0.33, with the Price to Cash per share for the same quarter was set at 0.16.
BNGO Stock Performance Analysis:
Bionano Genomics Inc [BNGO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -19.20. With this latest performance, BNGO shares dropped by -14.64% in over the last four-week period, additionally sinking by -69.76% over the last 6 months – not to mention a drop of -85.24% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNGO stock in for the last two-week period is set at 37.70, with the RSI for the last a single of trading hit 33.27, and the three-weeks RSI is set at 39.46 for Bionano Genomics Inc [BNGO]. The present Moving Average for the last 50 days of trading for this stock 0.2386, while it was recorded at 0.1966 for the last single week of trading, and 0.5441 for the last 200 days.
Insight into Bionano Genomics Inc Fundamentals:
Bionano Genomics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.99 and a Current Ratio set at 1.43.
Bionano Genomics Inc [BNGO] Institutonal Ownership Details
There are presently around $12.81%, or 12.83%% of BNGO stock, in the hands of institutional investors.
